Steeve Néron
Corporate Officer/Principal presso TETRA BIO-PHARMA INC.
Profilo
Steeve Néron is currently the Director at TALLC Corp., Inc. and the Chief Commercial Officer at Tetra Bio-Pharma, Inc. He previously worked as the Senior Portfolio Manager at Valeant Canada Ltd.
from 2013 to 2018.
Mr. Néron completed his undergraduate degree from Université du Québec à Chicoutimi in 1986.
Posizioni attive di Steeve Néron
Società | Posizione | Inizio |
---|---|---|
TETRA BIO-PHARMA INC. | Corporate Officer/Principal | 17/09/2020 |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Director/Board Member | - |
Precedenti posizioni note di Steeve Néron
Società | Posizione | Fine |
---|---|---|
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Corporate Officer/Principal | 01/02/2018 |
Formazione di Steeve Néron
Université du Québec à Chicoutimi | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
TETRA BIO-PHARMA INC. | Health Technology |
Aziende private | 2 |
---|---|
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Health Technology |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |
- Borsa valori
- Insiders
- Steeve Néron